Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Pharm Bull ; 38(12): 1879-90, 2015.
Article in English | MEDLINE | ID: mdl-26632180

ABSTRACT

A lower serum cholesterol level was recently shown to be one of the causes of stroke in an epidemiological study. Spontaneously hypertensive rats stroke-prone (SHRSP) have lower serum cholesterol levels than normotensive Wistar-Kyoto rats (WKY). To elucidate the mechanisms responsible for the lower serum cholesterol levels in SHRSP, we determined whether the amounts of cholesterol biosynthetic enzymes or the receptor and transporter involved in cholesterol uptake and efflux in the liver were altered in SHRSP. When the mRNA levels of seven cholesterol biosynthetic enzymes were measured using real-time polymerase chain reaction (PCR), farnesyl pyrophosphate synthase and squalene epoxidase (SQE) levels in the liver of SHRSP were significantly lower than those in WKY. SQE protein levels were significantly reduced in tissues other than the brain of SHRSP. No significant differences were observed in low-density lipoprotein (LDL) receptor (uptake of serum LDL-cholesterol) or ATP-binding cassette transporter A1 (efflux of cholesterol from the liver/formation of high-density lipoprotein (HDL)) protein levels in the liver and testis between SHRSP and WKY, whereas scavenger receptor class B type 1 (SRB1: uptake of serum HDL-cholesterol) protein levels were higher in the livers of SHRSP. These results indicated that the lower protein levels of SQE and higher protein levels of SRB1 in the liver were involved in the reduced serum cholesterol levels in SHRSP.


Subject(s)
Cholesterol/blood , Hypertension/metabolism , Liver/metabolism , Receptors, Scavenger/metabolism , Squalene Monooxygenase/metabolism , Stroke/metabolism , ATP-Binding Cassette Transporters/metabolism , Animals , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Hypertension/blood , Hypertension/genetics , Lipoproteins/metabolism , Male , RNA, Messenger/genetics , Rats, Inbred SHR , Rats, Inbred WKY , Real-Time Polymerase Chain Reaction , Squalene Monooxygenase/genetics , Stroke/blood , Stroke/genetics
2.
Biosci Biotechnol Biochem ; 79(11): 1759-70, 2015.
Article in English | MEDLINE | ID: mdl-26158200

ABSTRACT

Hypocholesterolemia has been epidemiologically identified as one of the causes of stroke (cerebral hemorrhage). We previously reported that lower protein levels of mevalonate pyrophosphate decarboxylase (MPD), which is responsible for reducing serum cholesterol levels in stroke-prone spontaneously hypertensive rats (SHRSP), in the liver were caused by a reduction in mRNA levels. However, the mechanism responsible for reducing MPD expression levels in the SHRSP liver remains unclear. Thus, we compared microRNA (miR)-214 combined with the 3'-untranslated region of MPD mRNA and heterogeneous nuclear RNA (hnRNA) between SHRSP and normotensive Wistar Kyoto rats (WKY). miR-214 levels in the liver were markedly higher in SHRSP than in WKY, whereas hnRNA levels were significantly lower. These results indicate that the upregulation of miR-214 and downregulation of MPD transcription in the liver both play a role in the development of hypocholesterolemia in SHRSP.


Subject(s)
Carboxy-Lyases/biosynthesis , Cholesterol/deficiency , Hypertension/genetics , MicroRNAs/genetics , Stroke/genetics , Animals , Carboxy-Lyases/genetics , Carboxy-Lyases/metabolism , Cholesterol/metabolism , Disease Models, Animal , Gene Expression Regulation, Enzymologic , Humans , Hypertension/enzymology , Hypertension/metabolism , Liver/enzymology , Liver/metabolism , MicroRNAs/metabolism , RNA, Messenger/biosynthesis , Rats , Rats, Inbred SHR , Stroke/enzymology , Stroke/pathology , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...